Characterization oft cell repertoire in patients with graft-versus- leukemia after donor lymphocyte infusion

Journal of Clinical Investigation

Volumn 100, Issue 4, 1997, Pages 855-866

  Claret, Emmanuel J ^a   Alyea, Edwin P ^a   Orsini, Enrica ^a   Pickett, Christopher C ^a   Collins, Heather ^a   Wang, Yulan ^a   Neuberg, Donna ^a,b   Soiffer, Robert J ^a   Ritz, Jerome ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic bone marrow transplantation; CD4 lymphocyte; Chronic myelocytic leukemia; Donor lymphocyte infusion; T cell receptor; T cell repertoire

Indexed keywords

CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR; CD3 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HELPER CELL; HUMAN; HUMAN CELL; INFUSION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CLONE; CLASSIFICATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; TIME; TRANSPLANTATION;

ADULT; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; FEMALE; GRAFT VS HOST REACTION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TIME FACTORS;

EID: 0030610153     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119601     Document Type: Article

References (45)

1. Antin, J.H. 1993. Graft-versus-leukemia: no longer an epiphenomenon. Blood. 82:2273-2277.
2. Kolb, H.J., J. Mittermuller, C. Clem, E. Holler, G. Ledderose, G. Brehm, M. Heim, and W. Wilmanns. 1990. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:2462-2465.
3. Kolb, H.J., A. Schattenberg, J.M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, and D. Niederwieser. 1995. Graft-versus-leukemia effect of donor lymphocyte ransfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 86:2041-2050.
4. Porter, D.L., M.S. Roth, C. McGarigle, J.L. Ferrara, and J.H. Antin. 1994. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 330:100-106.
5. Slavin, S., E. Naparstek, A. Nagler, A. Ackerstein, S. Samuel, J. Kapelushnik, C. Brautbar, and R. Or. 1996. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood. 87:2195-2204.
6. Collins, R., O. Shpilberg, W. Drobyski, D. Porter, S. Giralt, R. Champlin, S. Goodman, S. Wolff, C. Verfaillie, and A. List. 1997. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15:433-444.
7. Marmont, A.M. 1993. The graft versus leukemia (GVL) effect after allogeneic bone marrow transplantation for chronic myelogenous leukemia (CML). Leuk. Lymphoma. 11:221-226.
8. Horowitz. M.M., R.P. Gale, P.M. Sondel, J.M. Goldman, J. Kersey, H.J. Kolb, A.A. Rimm, O. Ringden, C. Rozman, and B. Speck. 1990. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 75:555-562.
9. Giralt, S.A., and R.E. Champlin. 1994. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood. 84:3603-3612.
10. Goldman, J.M., R.P. Gale, M.M Horowitz, J.C. Biggs, R.E. Champlin, E. Gluckman, R.G. Hoffmann, S.J. Jacobsen, A.M. Marmont, and P.B. McGlave. 1988. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann. Intern. Med. 108:806-314.
11. Marmont, A.M., M.M. Horowitz, R.P. Gale, K. Sobocinski, R.C. Ash, D.W. van Bekkum, R.E. Champlin, K.A. Dicke, J.M. Goldman, and R.A. Good. 1991. T-cell depletion of HLA-identical transplants in leukemia. Blood. 78:2120-2130.
12. Weiden, P., K. Sullivan, N. Flournoy, R. Storb, and E. Thomas. 1981. Anti-leukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304: 1529-1533.
13. Weiden, P.L., M.S. Flournoy, E.D. Thomas, R. Prentice, A. Fefer, C.D. Buckner, and R. Storb. 1979. Anti-leukemic effect of graft-versus-host-disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300:1068-1073.
14. Weisdorf, D.J., M.E. Nesbit, N.K. Ramsay, W.G. Woods, A.I. Goldman, T.H. Kim, D.D. Hurd, P.B. McGlave, and J.H. Kersey. 1987. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J. Clin. Oncol. 5:1348-1355.
15. Gaschet, J., M.A. Trevino, M. Cherel, R. Vivien, A. Garcia-Sahuquillo, M.M. Hallet, M. Bonneville, J.L. Harrousseau, R. Bragado, N. Milpied, and H. Vie. 1996. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood. 87:2345-2353.
16. Faber, L.M., S.A.P. van Luxemburg-Heijs, W.F.J. Veenhof, R. Willemze, and J.H.F. Falkenburg. 1995. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood. 86:2821-2828.
17. Mackinnon, S., E.B. Papadopoulos, M.H. Carabasi, L. Reich, N.H. Collins, F. Boulad, H. Castro-Malaspina, B.H. Childs, A.P. Gillio, and N.A. Kernan. 1995. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 86:1261-1268.
18. Giralt, S., J. Hester, Y. Huh, C. Hirsch-Ginsberg, G. Rondon, D. Seong, M. Lee, J. Gajewski, K. Van Besien, and I. Khouri. 1995. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 86:4337-4343.
19. Mehta, J. 1993. Graft-versus-leukemia reactions in clinical bone marrow transplantation. Leuk. Lymphoma. 10:427-432.
20. Rowen, L., B.F. Koop, and L. Hood. 1996. The complete 685-kilobase DNA sequence of the human β T cell receptor locus. Science (Wash. DC). 272: 1755-1762.
21. Yamanaka, K., W.W. Kwok, E.M. Mickelson, S. Masewicz, F. Smith, and G.T. Nepom. 1993. Selective T-cell-receptor gene usage in allorecognition and graft-versus-host disease. Transplantation (Baltimore). 55:1167-1175.
22. Dietrich, P.Y., A. Caignard, A. Diu, C. Genevee, J.L. Pico, M. Henry-Amar, J. Bosq, E. Angevin, F. Triebel, and T. Hercend. 1992. Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 80:2419-2424.
23. Dietrich, P.Y., A. Caignard, A. Lim, V. Chung, J.L. Pico, C. Pannetier, P. Kourilsky, T. Hercend, J. Even, and F. Triebel. 1994. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84:2815-2820.
24. Kubo, K., K. Yamanaka, H. Kiyoi, H. Fukutani, M. Ito, R. Hayakawa, R. Ohno, and T. Naoe. 1996. Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation. Blood. 87:3019-3026.
25. Liu, X., V. Chesnokova, S.J. Forman, and D.J. Diamond. 1996. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease. Blood. 87:3032-3044.
26. DeBruyne, L.A., J.P. Lynch, A. Baker, R. Florn, G.M. Deeb, R.I. Whyte, and D.K. Bishop. 1996. Restricted Vβ usage by T cells infiltrating rejecting human lung allografts. J. Immunol. 156:3493-3500.
27. Roux, E., C. Helg, F. Dumont-Girard, B. Chapuis, M. Jeannet, and E. Roosnek. 1996. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood. 87:3984-3992.
28. Soiffer, R.J., C. Murray, P. Mauch, K.C. Anderson, A.S. Freedman, S.N. Rabinowe, T. Takvorian, M.J. Robertson, N. Spector, and R. Gonin. 1992. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J. Clin. Oncol. 10:1191-2000.
29. Delage, R., R.J. Soiffer, K. Dear, and J. Ritz. 1991. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood. 78:2759-2767.
30. Pichert, G., D. Roy, R. Gonin, E. Alyea, R. Belanger, M. Gyger, C. Perreault, Y. Bonny, I. Lerra, and C. Murray. 1995. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. J. Clin. Oncol. 13: 1704-1713.
31. Choi, Y.W., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin superantigens with human T cells. Proc. Natl. Acad. Sci. USA. 86:8941-8945.
32. Genevee, C., A. Diu, J. Nierat, A. Caignard, P.Y. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261-1269.
33. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, and P. Kourilsky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807-2818.
34. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA. 90:4319-4323.
35. Gorski, J., M. Yassai, X. Zhu, B. Kissela, C. Keever, and N. Flomenberg. 1994. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J. Immunol. 152:5109-5119.
36. Hingorani, R., I.-H. Choi, P. Akolkar, B. Gulwani-Akolkar, R. Pergolizzi, J. Silver, and P. Gregersen. 1993. Clonal predominance of T cell receptors within the CDS+ CD45RO+ subset in normal human subjects. J. Immunol. 151:5762-5769.
37. Gaschet, J., A. Lim, L. Liem, R. Vivien, M.M. Hallet, J.L. Harousseau, J. Even, E. Goulmy, M. Bonneville, N. Milpied, and H. Vie. 1996. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J. Clin. Invest. 98:100-107.
38. thor Straten, P., J.C. Becker, T. Seremet, E.B. Broker, and J. Zeuthen. 1996. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J. Clin. Invest. 98:279-284.
39. Akatsuka, Y., C. Cerveny, and J. Hansen. 1996. T cell receptor clonal diversity following allogeneic marrow grafting. Hum. Immunol. 48:125-134.
40. Roux, E., C. Helg, B. Chapuis, M. Jeannet, and E. Roosnek. 1996. T-cell repertoire complexity after allogeneic bone marrow transplantation. Hum. Immunol. 48:135-138.
41. Callan, M.F.C., N. Steven, P. Krausa, J.D.K. Wilson, P.A.H. Moss, G.M. Gillespie, J.I. Bell, A.B. Rickinson, and A.J. McMichael. 1996. Large clonal expansions of CD8+ Tcells in acute infectious mononucleosis. Nat. Med. 2:906-911.
42. Akolkar, P., B. Gulwani-Akolkar, R. Pergolizzi, R. Bigler, and J. Silver. 1993. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:2761-2773.
43. Masuko, K., S. Kato, M. Hagihara, F. Tsuchida, Y. Takemoto, K. Izawa, T. Kato, S. Yamamori, Y. Mizushima, and K. Nishioka. 1996. Stable clonal expansion of T cells induced by bone marrow transplantation. Blood. 87:789-799.
44. Gorochov, G., P. Debre, V. Leblond, B. Sadat-Sowti, F. Sigaux, and B. Autran. 1994. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood. 83:587-595.
45. Goulmy, E., R. Schipper, J. Pool, E. Blokland, J.H. Falkenburg, J. Vossen, A. Grathwohl, G. B. Vogelsang, H.C. van Houwelingen, and J.J. van Rood. 1996. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334:281-285.